GSK-3β/β-catenin cascades have been reported that play a crucial role in the onset of depressive symptoms in animal models and thus have become a target of interest for depressive symptom alleviation and elucidation of the pathogenesis of depression [10–14]. Here, GSK3B is linked to depressive disorder.